Comparison of Stereotactic Body Radiation Therapy Versus Surgery for Multiple Primary Lung Cancers After Prior Radical Resection: A Multicenter Retrospective Study

Overview

Journal Clin Transl Radiat Oncol

Specialty Oncology

Date 2023 Mar 20

PMID 36936471

Authors

Baiqiang Dong

Runzhe Chen

Xuan Zhu

Qing Wu

Jianan Jin

Wenqing Wang

Yujia Zhu

Hui Jiang

Nan Bi

Xu Wang

Xiaofang Xu

Yujin Xu

Ming Chen

Affiliations

Soon will be listed here.

Abstract

Background: Patients who previously underwent surgical resection of initial primary lung cancer are at a high risk of developing multiple primary lung cancers (MPLCs). The purpose of this study was to compare the efficacy and safety between stereotactic body radiation therapy (SBRT) and surgery for MPLCs patients after prior radical resection for the first lung cancers.

Methods: In this multicenter retrospective study, eligible MPLC patients with tumor diameter of 5.0 cm or less at N0M0 who underwent SBRT or reoperation between January 2013 and August 2020 were enrolled. The primary endpoint was the 3-year locoregional recurrence and treatment-related toxicity. Kaplan-Meier method was used to calculate survival rates. The χ test was adapted to assess the difference of categorical variables between the two subgroup patients.

Results: A total of 203 (73 in the SBRT group and 130 in the surgery group) patients from three academic cancer centers were evaluated with a median follow-up of 38.3 months. The cumulative 1-, 2-, and 3-year incidences of locoregional recurrence were 5.6 %, 7.0 % and 13.1 % in the SBRT group versus 3.2 %, 4.8 % and 7.4 % in the surgery group, respectively [hazard ratio (HR), 1.97; 95 % confidence interval (CI), 0.74-5.24; = 0.14]. The cancer-specific survival rates were 95.9 %, 94.5 % and 88.1 % versus 96.9 %, 94.6 % and 93.8 % in the SBRT and surgery groups respectively (HR, 1.72; 95 % CI, 0.67-4.44; = 0.23). In the SBRT group, two patients (2.7 %) suffered from grade 3 radiation pneumonitis, while in the surgery group, grade 3 complications occurred in four (3.1 %) patients, and four cases were expired due to pneumonia or pulmonary heart disease within 90 days after surgery.

Conclusions: SBRT is an effective therapeutic option with limited toxicity compared to surgery for patients with MPLCs after prior radical surgical resection, and it could be considered as an alternative treatment for those patients.

Citing Articles

Prognostic analysis of helical tomotherapy stereotactic body radiotherapy in multiple primary or second primary lung cancers.

Ma J, Xu X, Huang W, Hu Y, Chen G, He J BMC Cancer. 2025; 25(1):118.

PMID: 39844108 PMC: 11752805. DOI: 10.1186/s12885-025-13540-2.

Diagnosis and management of multiple primary lung cancer.

Dong H, Tian Y, Xin S, Jiang S, Guo Y, Wan Z Front Oncol. 2024; 14:1392969.

PMID: 39411141 PMC: 11473257. DOI: 10.3389/fonc.2024.1392969.

[Recent Advances in Diagnosis and Treatment Strategies for Multiple Primary Lung Cancer].

Li B, Yang Z, Zhao Y, Chen Y, Huang Y Zhongguo Fei Ai Za Zhi. 2023; 26(11):863-873.

PMID: 38061888 PMC: 10714049. DOI: 10.3779/j.issn.1009-3419.2023.102.44.

FLASH Radiotherapy: A FLASHing Idea to Preserve Neurocognitive Function.

Jo H, Oh T, Lee Y, Kang G, Park H, Ahn G Brain Tumor Res Treat. 2023; 11(4):223-231.

PMID: 37953445 PMC: 10641319. DOI: 10.14791/btrt.2023.0026.

Editorial: Stereotactic body radiotherapy for lung cancer.

Liu A, Kroeze S Front Oncol. 2023; 13:1206736.

PMID: 37188178 PMC: 10175820. DOI: 10.3389/fonc.2023.1206736.

References

Griffioen G, Lagerwaard F, Haasbeek C, Slotman B, Senan S . A brief report on outcomes of stereotactic ablative radiotherapy for a second primary lung cancer: evidence in support of routine CT surveillance. J Thorac Oncol. 2014; 9(8):1222-5. DOI: 10.1097/JTO.0000000000000218. View

Chang J, Liu Y, Zhu Z, Welsh J, Gomez D, Komaki R . Stereotactic ablative radiotherapy: a potentially curable approach to early stage multiple primary lung cancer. Cancer. 2013; 119(18):3402-10. PMC: 3775964. DOI: 10.1002/cncr.28217. View

Chang J, Senan S, Paul M, Mehran R, Louie A, Balter P . Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer: a pooled analysis of two randomised trials. Lancet Oncol. 2015; 16(6):630-7. PMC: 4489408. DOI: 10.1016/S1470-2045(15)70168-3. View

Tamura M, Matsumoto I, Tanaka Y, Saito D, Yoshida S, Kakegawa S . Comparison Between Stereotactic Radiotherapy and Sublobar Resection for Non-Small Cell Lung Cancer. Ann Thorac Surg. 2018; 107(5):1544-1550. DOI: 10.1016/j.athoracsur.2018.10.015. View

Kozower B, Larner J, Detterbeck F, Jones D . Special treatment issues in non-small cell lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2013; 143(5 Suppl):e369S-e399S. DOI: 10.1378/chest.12-2362. View

Senthi S, Haasbeek C, Lagerwaard F, Verbakel W, De Haan P, Slotman B . Radiotherapy for a second primary lung cancer arising post-pneumonectomy: planning considerations and clinical outcomes. J Thorac Dis. 2013; 5(2):116-22. PMC: 3621919. DOI: 10.3978/j.issn.2072-1439.2013.02.07. View

Han S, Rivera G, Tammemagi M, Plevritis S, Gomez S, Cheng I . Risk Stratification for Second Primary Lung Cancer. J Clin Oncol. 2017; 35(25):2893-2899. PMC: 5946715. DOI: 10.1200/JCO.2017.72.4203. View

Detterbeck F, Jones D, Kernstine K, Naunheim K . Lung cancer. Special treatment issues. Chest. 2003; 123(1 Suppl):244S-258S. DOI: 10.1378/chest.123.1_suppl.244s. View

Chi A, Liao Z, Nguyen N, Xu J, Stea B, Komaki R . Systemic review of the patterns of failure following stereotactic body radiation therapy in early-stage non-small-cell lung cancer: clinical implications. Radiother Oncol. 2010; 94(1):1-11. DOI: 10.1016/j.radonc.2009.12.008. View

10.

Martini N, Melamed M . Multiple primary lung cancers. J Thorac Cardiovasc Surg. 1975; 70(4):606-12. View

11.

Subotic D, Van Schil P, Grigoriu B . Optimising treatment for post-operative lung cancer recurrence. Eur Respir J. 2016; 47(2):374-8. DOI: 10.1183/13993003.01490-2015. View

12.

Hurkmans C, Cuijpers J, Lagerwaard F, Widder J, van der Heide U, Schuring D . Recommendations for implementing stereotactic radiotherapy in peripheral stage IA non-small cell lung cancer: report from the Quality Assurance Working Party of the randomised phase III ROSEL study. Radiat Oncol. 2009; 4:1. PMC: 2631491. DOI: 10.1186/1748-717X-4-1. View

13.

Cao C, Wang D, Chung C, Tian D, Rimner A, Huang J . A systematic review and meta-analysis of stereotactic body radiation therapy versus surgery for patients with non-small cell lung cancer. J Thorac Cardiovasc Surg. 2018; 157(1):362-373.e8. PMC: 6582640. DOI: 10.1016/j.jtcvs.2018.08.075. View

14.

Leroy T, Monnet E, Guerzider S, Jacoulet P, De Bari B, Falcoz P . Let us not underestimate the long-term risk of SPLC after surgical resection of NSCLC. Lung Cancer. 2019; 137:23-30. DOI: 10.1016/j.lungcan.2019.09.001. View

15.

Lou F, Huang J, Sima C, Dycoco J, Rusch V, Bach P . Patterns of recurrence and second primary lung cancer in early-stage lung cancer survivors followed with routine computed tomography surveillance. J Thorac Cardiovasc Surg. 2012; 145(1):75-81. DOI: 10.1016/j.jtcvs.2012.09.030. View

16.

Ferrari-Light D, Cerfolio R . Non-small cell lung cancer 2 cm or less: robotic segmentectomy sets the gold standard against non-surgical therapy. Ann Transl Med. 2019; 7(Suppl 3):S96. PMC: 6685859. DOI: 10.21037/atm.2019.04.51. View

17.

Takeda A, Sanuki N, Eriguchi T, Enomoto T, Yokosuka T, Kaneko T . Salvage stereotactic ablative irradiation for isolated postsurgical local recurrence of lung cancer. Ann Thorac Surg. 2013; 96(5):1776-82. DOI: 10.1016/j.athoracsur.2013.06.014. View

18.

Mollberg N, Ferguson M . Postoperative surveillance for non-small cell lung cancer resected with curative intent: developing a patient-centered approach. Ann Thorac Surg. 2013; 95(3):1112-21. DOI: 10.1016/j.athoracsur.2012.09.075. View

19.

Detterbeck F, Franklin W, Nicholson A, Girard N, Arenberg D, Travis W . The IASLC Lung Cancer Staging Project: Background Data and Proposed Criteria to Distinguish Separate Primary Lung Cancers from Metastatic Foci in Patients with Two Lung Tumors in the Forthcoming Eighth Edition of the TNM Classification for Lung.... J Thorac Oncol. 2016; 11(5):651-665. DOI: 10.1016/j.jtho.2016.01.025. View

20.

Dong B, Wang J, Xu Y, Hu X, Shao K, Li J . Comparison of the Efficacy of Stereotactic Body Radiotherapy versus Surgical Treatment for Early-Stage Non-Small Cell Lung Cancer after Propensity Score Matching. Transl Oncol. 2019; 12(8):1032-1037. PMC: 6542747. DOI: 10.1016/j.tranon.2019.04.015. View